Friday, July 29, 2016

Full-Dose NOAC Safe With Single Dose-Reduction Factor (CME/CE)

(MedPage Today) -- "Should be the preferred dose" of apixaban (Eliquis) unless more factors
via Full-Dose NOAC Safe With Single Dose-Reduction Factor (CME/CE)
by

No comments:

Post a Comment